Announced details
The companies have already formed sales partnerships for multiple products. They have now entered into a sales partnership agreement in Japan for these 2 products.
Head office: Bunkyo-ku, Tokyo; President and Representative Director: Horiuchi Hiroyuki (堀内裕之). The company offers a wide range of prescription medicines specializing in the feet and lower limbs that support people's ability to walk.
The impact of this matter on the company's results is expected to be minor. If any impact is anticipated, it will be disclosed promptly.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Opalmon Tablets 5 μg, Prostandin Ointment 0.003% |
| Counterparty | KAKEN PHARMACEUTICAL CO.,LTD. |
| Counterparty overview | Head office: Bunkyo-ku, Tokyo; President and Representative Director: Horiuchi Hiroyuki (堀内裕之). The company offers a wide range of prescription medicines specializing in the feet and lower limbs that support people's ability to walk. |
| Relationship with the Company | The companies have already formed sales partnerships for multiple products. They have now entered into a sales partnership agreement in Japan for these 2 products. |
| Contract Date | 13 May 2026 |
| Launch date | The timing of the sales launch by KAKEN PHARMACEUTICAL CO.,LTD. will be determined through further discussions. The transfer of the marketing authorization is scheduled for around November 2026. |
| Applicable area | Orthopedics, Dermatology |
| Impact on Business Performance | The impact of this matter on the company's results is expected to be minor. If any impact is anticipated, it will be disclosed promptly. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.KAKEN PHARMACEUTICAL CO.,LTD. has extensive results and experience in orthopedics and dermatology, and it was determined that entering into an agreement with the company was the optimal choice.